ATARA Biotherapeutics (ATRA) to Cut 25% Staff

On January 8, 2024, ATARA Biotherapeutics (NASDAQ: ATRA)announced a reduction in its workforce that will impact approximately 25% of its current employees. The Company expects to substantially complete the workforce reduction by May 2024.

The Company expects to recognize approximately $4.5 million in total for severance and related benefits for employees laid off under the reduction in force. These charges are primarily one-time termination benefits and are primarily cash charges. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the workforce reduction

You May Also Be Interested In

• PayPal on watch amid layoffs rumors
• Agilent Technologies filed for proposed debt offering
• Tencent Music plans senior unsecured notes offering